Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155)
Clinical trial NCT02684617 · TERMINATED
Trial details
- NCT number
- NCT02684617
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-29
- Primary completion
- 2020-04-06
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.